BANK VONTOBEL/PUT/ABBOTT LABORATORIES/120/0.1/20.09.24 Stock

Warrant

DE000VD0RFA2

Market Closed - Deutsche Boerse AG 02:05:04 2024-05-17 pm EDT
1.46 EUR +3.55% Intraday chart for BANK VONTOBEL/PUT/ABBOTT LABORATORIES/120/0.1/20.09.24
Current month+12.31%
1 month+8.96%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-17 1.46 +3.55%
24-05-16 1.41 -2.08%
24-05-15 1.44 -5.26%
24-05-14 1.52 +7.04%
24-05-13 1.42 0.00%

Delayed Quote Deutsche Boerse AG

Last update May 17, 2024 at 02:05 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer Vontobel Vontobel
WKN VD0RFA
ISINDE000VD0RFA2
Date issued 2024-02-21
Strike 120 $
Maturity 2024-09-20 (124 Days)
Parity 10 : 1
Emission price 0.74
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.52
Lowest since issue 0.54
Spread 0.01
Spread %0.67%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
104.1 USD
Average target price
126.1 USD
Spread / Average Target
+21.19%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW